Abstract
A method of studying the effect of drugs on the lower urinary tract is described, using cord-injured patients with detrusor hyperreflexia. In this study 19 patients received intravenous phentolamine. This alpha-adrenergic blockade produced a significant reduction in the maximum voiding detrusor pressure, voided volumes and peak flow rates with no reduction of outflow tract obstruction.
Similar content being viewed by others
Article PDF
References
Clarke, S J & Thomas, D G (1981). Characteristics of the urethral pressure profile in flaccid male paraplegics. Brit. J. Urol., 53, 157–161.
Eaton, A C & Bates, C P (1982). An in vitro physiological study of normal and unstable human detrusor muscle. Brit. J. Urol., 54, 653–657.
Hachen, H J (1980). Clinical and urodynamic assessment of alpha-adrenolytic therapy in patients with neurogenic bladder function. Paraplegia, 18, 229–238.
Mobley, D F (1976). Phenoxybenzamine in the management of neurogenic vesical dysfunction. J. Urol., 116, 737–738.
Olsson, C A, Siroky, M B & Krane, R J (1977). The phentolamine test in neurogenic bladder dysfunction. J. U rol., 117, 481–485.
Philp, N H, Thomas, D G & Clarke, S J (1980). Drug effects on the voiding cystometrogram: a comparison of oral bethanecol and carbachol. Brit. J. Urol., 52, 484–487.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomas, D., Philp, N., McDermott, T. et al. The use of urodynamic studies to assess the effect of pharmacological agents with particular references to alpha-adrenergic blockade. Spinal Cord 22, 162–167 (1984). https://doi.org/10.1038/sc.1984.29
Issue Date:
DOI: https://doi.org/10.1038/sc.1984.29
Keywords
This article is cited by
-
Update on bladder evaluation recommendations and bladder management guideline in patients with spinal cord injury
Current Bladder Dysfunction Reports (2007)
-
Prazosin treatment of neurological patients with lower urinary tract dysfunction
International Urogynecology Journal (1993)